Accepted
at 6:12 p.m. Aug, 09, 2024
by
Ahmed7
Type of change:
Updated content
Rationale for change
sketchy
Source: Other - sketchy
Before
After
Sketchy
Sketchy
Sketchy
Sketchy
Text
The {{c1::pneumococcal conjugate vaccine PCV20::specific}} is given to children < 5 years and adults ≥ 50 to prevent Streptococcus pneumoniae infection
Extra
- This vaccine is a polysaccharide capsule and protein conjugate providing long-lasting immunity against 20 serotypes
- Provides no significant immunity against nonvaccinated serotypes; therefore, infection can still occur
- PCV15 can can be used as an alternative in children
- In adults ≥ 50, PCV20 eliminates the need to administer PCV15 followed by PPSV23
- This card previously tested old guidelines, which recommended vaccination at ≥ 65 years of age with PPSV23 alone. It's unknown which guidelines UWorld and/or the NBME will test on (Nov 2025)
- Provides no significant immunity against nonvaccinated serotypes; therefore, infection can still occur
- PCV15 can can be used as an alternative in children
- In adults ≥ 50, PCV20 eliminates the need to administer PCV15 followed by PPSV23
- This card previously tested old guidelines, which recommended vaccination at ≥ 65 years of age with PPSV23 alone. It's unknown which guidelines UWorld and/or the NBME will test on (Nov 2025)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
















Sketchy 2

PCV15 covers the same strains as PCV13



Watch Vaccination Schedule 1

PCV15 covers the same strains as PCV13



Watch Vaccination Schedule 1
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo
.jpg)
.jpg)
.jpg)
.jpg)
Bootcamp
Watch associated Bootcamp video - Streptococcus: Streptococcus Pneumoniae
Watch associated Bootcamp video - Vaccinations: Subunit Polysaccharide Vaccines
Watch associated Bootcamp video - Vaccinations: Subunit Polysaccharide Vaccines
OME
Additional Resources
Empty field
One by one
Empty field
